Shankar BalasubramanianFMedSci, FRS
Shankar Balasubramanian is the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge. He is the co-inventor of the leading next generation sequencing methodology which has made routine, accurate, low-cost sequencing of human genomes a reality. He created Solexa sequencing, co-founded the biotech company Solexa to commercialise the technology and has remained a senior advisor to Solexa then Illumina over the past decade. He has made other seminal contributions to the field of nucleic acids and is a recognised leader of chemical biology and its application to molecular medicine.